Our Partners ASOP, ASOP EU and CSIP have hosted a seminar on ‘Protecting Patients from Falsified Medicines Online’ in Brussels. Officials from the European Commission, the United States government, as well as key stakeholders from the US and EU healthcare and Internet commerce communities, patient groups, and other non-government organisations Read more…
Update: Dr. Thomas Egwang has launched a campaign, EquipmentAgainstFakes, to help raise funds for his lab’s purchasing of equipment for detecting fake medicines. Click here to see what you can do to help! My name is Dr. Thomas Egwang, and I am the Senior Scientist at Med Biotech Laboratories in Uganda. Read more…
Tony explains the danger of fake medicines to Max and why they endanger our lives. The main topics explain what counterfeit medicines are, the scope of the phenomenon, the Internet problem, and of course the solutions. A fun and complete way to be informed about a threat to global public Read more…
Tony explique à Max le danger que représente les faux médicaments et pourquoi ils mettent en danger nos vies. Les principaux thèmes abordés traitent de ce qu’est la contrefaçon de médicaments, l’ampleur du phénomène, la problématique Internet, et bien sûr les solutions. Une façon ludique et complète d’être informé sur Read more…
My name is Marie Lamy and I am conducting a doctoral study at the London School of Hygiene and Tropical Medicine. I am researching the institutional mechanisms to regulate and prevent the availability of fake medicines in the Greater Mekong Region of Southeast Asia, comprised of Myanmar, Thailand, Lao, Cambodia, Read more…
Bloomberg news reported yesterday that fake antibiotics are among the world’s most common fake medicines, and that this is feeding into the prevalence of global antimicrobial drug resistance. According to the World Health Organization (WHO), conducting a surveillance program on fake antibiotics in 80 countries around the world, drug resistance Read more…
This week, the US Food and Drug Administration (FDA) issued its first guidance under Title II of the Drug Quality and Security Act, the “Drug Supply Chain Security Act”. The FDA advises drug supply chain stakeholders, which includes wholesalers, regulatory officials, care-givers and patients, to make note of potential signs Read more…
Americans are likely to be exposed to unsafe medications when they purchase from fake online pharmacies that aren’t licensed in the United States. Only legitimate pharmacies with valid state licenses are safe to purchase from online. Visit PSM’s website to learn more about purchasing medication safely and affordably in the US.
Check out the article “Fight the Fakes Campaign Adds Bevy of New Partners” in Outsourcing Pharma here.
